World Health Organization – Page 11 – Communicable Diseases Research

Convolutional Neural Network Applied to SARS-CoV-2 Sequence Classification

SARS-CoV-2 서열 분류에 적용된 컨볼루션 신경망

Article

Published on 2022-07-312022-09-11
Journal: Sensors (Basel, Switzerland) [Category] COVID19(2023년), SARS, 변종,

MIS-C and co-infection with P. vivax and P. falciparum in a child: a clinical conundrum

소아에서 MIS-C 및 P. vivax 및 P. falciparum과의 동시 감염: 임상적 수수께끼

Case Reports

Published on 2022-07-272022-09-11
Journal: Italian Journal of Pediatrics [Category] COVID19(2023년), SARS, 말라리아, 치료기술,

[키워드] Case report children clearance clinical condition Co-infection coronavirus disease Coronavirus disease 2019 COVID 19 COVID-19 COVID-19 symptom criteria Critical Diagnosis Early detection effective Endemic Epidemic Health Health Organization Infection infections Inflammatory Intravenous immunoglobulin malaria management Methylprednisolone MIS-C Multisystem inflammatory syndrome nasopharyngeal occur P. falciparum Patient patients with SARS-CoV-2 PCR Plasmodium Plasmodium vivax risk SARS CoV2 SARS-COV-2 infection SARS-CoV2 Symptom syndrome the patient were used WHO World Health Organization worsened
[DOI] 10.1186/s13052-022-01311-9 PMC 바로가기 [Article Type] Case Reports

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

Article

Published on 2022-07-222022-10-06
Journal: EClinicalMedicine [Category] 진단,

[키워드] adverse event adverse events anti-SARS-CoV-2 approach AS03 cellular immunity CEPI clinical study conducted COVID-19 COVID-19 pandemic deviation displaying distribution dose eligible Emergency use enrolled evaluate evaluated flu vaccine foundation geometric mean concentration group groups healthy hospital Humoral immunity IgG antibody immunogenic immunogenicity injection site pain Intervention intramuscularly Investment Local Melinda Gate mitigate myalgia naïve nanoparticle nanoparticle vaccine neutralizing antibody observer-blinded outcome participant per-protocol phase Placebo placebo-controlled primary immunogenicity Protein protocol pseudovirus randomised RBD RBD IgG reached reactogenicity receive recipient Recombinant protein recombinant protein vaccine Registered reported Safety SARS-CoV-2 SARS-COV-2 infection second dose Stage study enrollment Support supported systemic AE systemic AEs T-cell immune responses the receptor-binding domain the vaccine titre Trial vaccination vaccination schedule Vaccine wild-type virus World Health Organization
[DOI] 10.1016/j.eclinm.2022.101569 PMC 바로가기 [Article Type] Article

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection

SARS-CoV-2 감염 진단을 위한 신속한 현장 진료 항원 검사

Review

Published on 2022-07-222022-09-11
Journal: The Cochrane database of systematic reviews [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제,

[키워드] 95% CI 95% confidence interval absence access Accuracy age Antigen antigen test antigen tests approach assays Asymptomatic average Bern bioRxiv brand can not carried Chain Reaction Characteristics checked CIs Cohort Compliance conducted COVID-19 COVID-19 pandemic COVID-19 testing criteria criterion Data collection database demonstrated described detect diagnosis of SARS-CoV-2 diagnostic Diagnostic accuracy diagnostic tests Effectiveness eligible epidemiological estimate Europe evaluate evaluated Evidence exposure to False positive False positives global health groups Health Organization healthcare help heterogeneity highest include independent indication Infection Interpretation investigated logistic regression models management Mass screening measure medRxiv molecular test National Open Access Other participant Participants Patient care point-of-care polymerase chain polymerase chain reaction population groups Positive predictive value positive result PPV Predictive value presence or absence Prevalence produced public health QUADAS-2 random-effect ranged Rapid rapid antigen test Rapid antigen tests Rapid diagnostic test reduce reducing reference reference standard Reference standards repeated reported Research respiratory respiratory sample resulting reverse transcription reverse transcription polymerase chain reaction RT-PCR RT-PCR testing SARS-CoV-2 SARS-COV-2 infection Schools screened screening procedure screening programmes searched second Selection sensitivities sensitivity Sensitivity and specificity Seven Signs and symptoms Source Specificities specificity study cohort Study design Symptom symptom onset symptom status symptomatic symptomatic and asymptomatic symptomatic participant symptomatic participants symptomatic people symptoms of COVID-19 test negative test result Testing to define Transmission Triage unique University of Bern variable Viral Viral load viral loads website were used WHO World Health Organization
[DOI] 10.1002/14651858.CD013705.pub3 PMC 바로가기 [Article Type] Review

A Method for Variant Agnostic Detection of SARS-CoV-2, Rapid Monitoring of Circulating Variants, and Early Detection of Emergent Variants Such as Omicron

SARS-CoV-2의 변이 불가지론적 검출, 순환 변이체의 신속한 모니터링 및 오미크론과 같은 새로운 변이체의 조기 검출을 위한 방법

Article

Published on 2022-07-202022-09-11
Journal: Journal of Clinical Microbiology [Category] COVID19(2023년), SARS, 변종, 치료기술,

[키워드] accelerate approach concerning COVID-19 Delta detect detection diagnostic test diagnostic tests effective Efficacy Genotype genotyping geographical distribution Health Organization healthcare in vitro in vitro diagnostics INDEL indels lab less Lineage marker monitoring mutations Next-generation sequencing NGS omicron polymorphism positive sample Prevalence prevalent public health quantity question raised Rapid reducing Reporting resources Responding retrospective reverse transcription PCR RT-PCR SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants sequence Sequencing significantly single-nucleotide SNPs Specific Strains transmission pattern transmission patterns utility Vaccines variant variants was determined WHO World Health Organization
[DOI] 10.1128/jcm.00342-22 PMC 바로가기 [Article Type] Article

Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020

COVID-19 전염병 동안 인플루엔자 음성 인플루엔자 유사 질병의 확산을 감지하기 위한 글로벌 인플루엔자 감시 시스템: 2015-2020년의 시계열 이상치 분석

Article

Published on 2022-07-192022-09-11
Journal: PLoS Medicine [Category] COVID19(2023년), SARS, 치료기술,

[키워드] Analysis analyzed ARIMA automated average baseline changes in Completeness country COVID-19 COVID-19 case COVID-19 pandemic data-driven detect disease emerging disease evaluate exceeded first positive Health Organization highest identify ILI Influenza interpolation limitation linear linear interpolation Missing data moving average National observation occurred Outbreaks outlier outliers pathogen performed Poland positive primary analysis reported response SARS-CoV-2 SARS-CoV-2 positivity sensitivity analysis Spain Spread spread of COVID-19 Standard deviation Surveillance surveillance data surveillance network System time training data used data World Health Organization
[DOI] 10.1371/journal.pmed.1004035 PMC 바로가기 [Article Type] Article

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody

SARS-CoV-2 중화 항체 검출을 위한 중화 분석 및 국제 표준 개요

Review

Published on 2022-07-182022-09-11
Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Antibody Response Antibody responses Antibody titer approach coronavirus coronavirus disease demonstrated detect determine disease disease outbreak Efficacy ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Health Organization International international standard international standard for SARS-CoV-2 International standards lateral flow microneutralization Microneutralization assay MONITOR Neutralization assay neutralization assays Neutralizing antibodies neutralizing antibody neutralizing antibody detection Neutralizing antibody titer outbreak outcome Patient respiratory SARS-CoV-2 SARS-CoV-2 pseudotype virus Serological assay serological assays severe acute respiratory syndrome Coronavirus Standard to define Vaccine vaccine efficacy World Health Organization
[DOI] 10.3390/v14071560 PMC 바로가기 [Article Type] Review

Multisystem Inflammatory Syndrome Associated With COVID-19 in Children (MIS-C): A Systematic Review of Studies From India

어린이의 COVID-19와 관련된 다기관 염증 증후군(MIS-C): 인도 연구의 체계적인 검토

Article

Published on 2022-07-152022-09-11
Journal: Indian pediatrics [Category] COVID19(2023년), MERS, SARS, 바이오마커,

[키워드] Admissions age article calculate children clinical Clinical features coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids Course COVID-19 database databases derangement disease course disease status Effect feature Features Fever Frequency Future gastrointestinal problem gastrointestinal problems GraphPad GraphPad software Health Organization Immunoglobulin India Inflammatory Inflammatory marker inflammatory markers intensive care Intravenous immunoglobulin IQR Kawasaki disease laboratory parameter Laboratory parameters majority male median MIS-C mortality rate NIH parameter Patient patients ranged reported required review SARS-COV-2 infection Screening Standard deviation syndrome systematic review the disease the mean Therapeutics Treatment was done was used World Health Organization
[DOI] 10.1007/s13312-022-2559-5 PMC 바로가기 [Article Type] Article

Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review

SARS-Cov-2 오미크론 변이체에 대한 COVID-19 백신의 체액 및 세포 면역 반응: 전신 검토

Review

Published on 2022-07-112022-09-11
Journal: International Journal of Biological Sciences [Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed B.1.1.529 booster booster dose cellular Cellular immune response cellular immune responses center contagious coronavirus 2 country COVID-19 vaccine Critical current dominant variant dose Effectiveness elicit elicited Future Genome Health Organization Heterologous homogenous homologous or heterologous humoral Humoral and cellular immune responses humoral immune response humoral immune response, cellular immune response immune Immune escape immune responses induce molecular basis multiple mutation multiple mutations mutated Mutation Neutralizing antibody response neutralizing antibody responses omicron Omicron variant PROTECT Protective public health question regimen regimens reported respiratory response robust S-protein SARS-CoV-2 SARS-CoV-2 strains SARS-CoV-2 virus Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus Systemic review systemically T cell T cell response the SARS-CoV-2 virus vaccination Vaccination strategy Vaccine variant VoC WHO World Health Organization
[DOI] 10.7150/ijbs.73583 PMC 바로가기 [Article Type] Review

Breastfeeding during the COVID-19 pandemic: what do we know so far?

COVID-19 전염병 동안 모유 수유: 우리는 지금까지 무엇을 알고 있습니까?

Review

Published on 2022-07-082022-09-11
Journal: Einstein [Category] COVID19(2023년), SARS, 치료기술,